The usefulness of bone turnover in predicting the response to transdermal estrogen therapy in postmenopausal osteoporosis

Journal of Bone and Mineral Research

Volumn 12, Issue 4, 1997, Pages 624-631

  Gonnelli, Stefano ^a   Cepollaro, C ^a   Pondrelli, C ^a   Martini, S ^a   Monaco, R ^a   Gennari, C ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CARBONATE; ESTRADIOL; ESTROGEN; GLUCONATE CALCIUM; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PATIENT MONITORING; POSTMENOPAUSE OSTEOPOROSIS; PREDICTION; RANDOMIZED CONTROLLED TRIAL; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; AGED; BONE AND BONES; BONE REMODELING; CALCIUM; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 0031002944     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.4.624     Document Type: Article

References (41)

1. Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC 1976 Long term prevention of postmenopausal osteoporosis by estrogen. Lancet 1:1038-1041.
2. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckmann EM 1979 Estrogen replacement therapy I: A 10-year prospective study in the relationship to osteoporosis. Obstet Gynccol 53:277-281.
3. Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund K, Transbol IB 1980 Prevention of early postmenopausal bone loss: Controlled 2-year study in 315 normal females. Eur J Clin Invest 10:273-279.
4. Lindsay R 1993 Hormone replacement therapy for prevention and treatment of osteoporosis. Am J Med 95 (Suppl 5A):37S-39S.
5. Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR 1980 Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. New Engl J Med 303:1195-1198.
6. Ettinger B, Genant HK, Cann CE 1985 Long term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 102:319-324.
7. Kiel DP, Felson DT, Anderson JJ, Wilson PWF, Moskowitz MA 1987 Hip fracture and the use of estrogens in postmenopausal women. New Engl J Med 317:1169-1174.
8. Lindsay R, Thome JF 1990 Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol 76:290-295.
9. Lafferty FW, Fiske ME 1994 Postmenopausal estrogen replacement: A long-term cohort study. Am J Med 97:66-77.
10. Nguyen TV, Graeme J, Sambrook PN, White CP, Kelly PJ, Eisman JA 1995 Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures. J Clin Endocrinol Metab 80:2709-2714.
11. Whitehead MI, Fraser D, Schenkel L, Crook D, Stevenson JC 1990 Transdermal administration of estrogen/progestagen hormone replacement therapy. Lancet 35:310-312.
12. Stevenson JC, Cust MP, Gangar KF, Hillard TC, Lees B, Whitehead MI 1990 Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. Lancet 336:265-269.
13. Hillard TC, Whitcroft SJ, Marsh MS, Ellerington MC, Lees B, Whitehead MI, Stevenson JC 1994 Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss. Osteoporosis Int 4:341-348.
14. Ettinger B, Grady D 1993 The waning effect of postmenopausal estrogen therapy on osteoporosis. New Engl J Med 329:1192-1193.
15. Marx CW, Dailey III GE, Cheney C, Vint II VC, Muchmore DB 1992 Do estrogens improve bone mineral density in osteoporotic women over age 65? J Bone Miner Res 7:1275-1279.
16. Lufkin EG, Wahner HW, O'Fallon WM, Hodgson SF, Kotowicz MA, Lane AW, Judd HL, Caplan RH, Riggs BL 1992 Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 117:1-9.
17. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PWF, Anderson JJ 1993 The effect of postmenopausal estrogen therapy on bone density in elderly women. New Engl J Med 329:1141-1146.
18. Hasling C, Charles P, Tagehøj Jensen F, Mosekilde L 1994 A comparison of the effects of oestrogen/progestogen, high-dose oral calcium, intermittent cyclic etidronate and an ADFR regime on calcium kinetics and bone mass in postmenopausal women with spinal osteoporosis. Osteoporosis Int 4:191-203.
19. Holland EFN, Leather AT, Studd JWW 1995 Increase in bone mass of older postmenopausal women with low mineral bone density after one year of percutaneous oestradiol implants. Br J Obstet Gynecol 102:238-242.
20. Rozenberg S, Gevers R, Peretz A, Vandromme J, Robjn C, Ham H 1993 Decrease of bone mineral density during estrogen substitution therapy. Maturitas 17:205-210.
21. Armamento-Villareal R, Civitelli R 1995 Estrogen action on the bone mass postmenopausal women is dependent on body mass and initial bone density. J Clin Endocrinol Metab 80:776-782.
22. Slemenda CW, Hui SL, Longcope C, Johnston Jr CC 1987 Sex steroids and bone mass. J Clin Invest 80:1261-1269.
23. Sherman SS, Tobin JD, Hollis BW, Gundberg CM, Roy TA, Plato CC 1992 Biochemical parameters associated with low bone density in healthy men and women. J Bone Miner Res 7:1123-1130.
24. Civitelli R, Gonnelli S, Zacchei F, Bigazzi S, Vattimo A, Avioli LV, Gennari C 1988 Bone turnover in postmenopausal osteoporosis: Effect of calcitonin treatment. J Clin Invest 82:1268-1274.
25. Parfitt AM, Mathews L, Rao D, Frame B, Kleerekoper M, Villanueva AR 1981 Impaired osteoblast function in metabolic bone disease. In: De Luca HF, Frost HM, Jee WS, Johnson CC, Parfitt AM (eds.) Osteoporosis: Recent Advances in Pathogenesis and Treatment. University Park Press, Baltimore, MD, U.S.A., pp. 321-330.
26. Whyte MP, Berfeld MA, Murphy WA, Avioli LV, Teitelbaum SL 1982 Postmenopausal osteoporosis: A heterogeneous disorder as assessed by histomorphometric analisys of iliac crest bone from untreated patients. Am J Med 72:193-202.
27. Delmas PD 1993 Biochemical markers of bone turnover. J Bone Miner Res 8 (Suppl 2):549-554.
28. Bollerslev J 1994 Biochemical markers used in the diagnosis and monitoring of osteoporosis. Scand J Clin Lab Invest 54 (Suppl 219):33-35.
29. 99mTc diphosphonate excretion as a simple method to quantify bone metabolism. Scand J Clin Lab Invest 44:105-109.
30. Prockop DJ, Udenfriend S 1960 A specific method for the analysis of hydroxyproline in tissues and urine. Anal Biochem 1:228-239.
31. Seyedin SM, Kung VT, Daniloff YN, Hesley RP, Gomez B, Nielsen LA, Rosen HN, Zuk RF 1992 Immunoassay for urinary pyridinoline: The new marker of body resorption. J Bone Miner Res 8:637-643.
32. Christiansen C, Lindsay R 1990 Estrogens, bone loss and preservation. Osteoporosis Int 1:7-13.
33. Lindsay R, Hart M, Clark DM 1983 The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 63:759-763.
34. Me Neeley SG, Schinfield JS, Stovall TG, Ling FW, Buxton BH 1991 Prevention of osteoporosis by medroxy-progesterone acetate in postmenopausal women. Int J Gynaecol Obstet 34:253-256.
35. Prestwood KM, Pilbeam CC, Burleson JA, Woodiel FN, Delmas P, Deftos LJ, Raisz LG 1994 The short term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Invest 79:366-371.
36. Parfitt AM 1980 Morphologic basis of bone mineral measure- ments: Transient and steady state effects of treatment in osteoporosis. Miner Electrolyte Metab 4:273-287.
37. Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, Licata AA, Ross P, Woodson III CC, Yanover MJ, Mysiw WJ, Kohse L, Rao MB, Steiger P, Richmond B, Chesnut III CH 1990 Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. New Engl J Med 323:73-79.
38. Kanis JA 1995 Treatment of osteoporosis in elderly women. Am J Med 98 (Suppl 2A):60-66.
39. 3 in oophorectomized women. J Clin Endocrinol Metab 71:1288-1293.
40. Civitelli R, Maioli M, Gonnelli S, Agnusdei D, Gennari C 1990 The potency of calcitonin in lowering serum calcium depends on bone turnover. In: C Christiansen, K Overgaard (eds.) Osteoporosis 1990. Copenhagen: Osteopress APS, pp. 1420-1422.
41. Riis BJ, Overgaard K, Christiansen C 1995 Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapy. Osteoporosis Int 5:276-280.